Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab–CHOP

Survivin is an inhibitor of apoptosis and is upregulated by Epstein–Barr virus (EBV) latent genes. Given the frequent association of EBV with lymphoid malignancies, survivin is expected to have prognostic value in diffuse large B-cell lymphoma (DLBCL). Thus, we measured the pretreatment serum level...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jung Yong, Ryu, Kyung Ju, Park, Chaehwa, Hong, Mineui, Ko, Young Hyeh, Kim, Won Seog, Kim, Seok Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355138/
https://www.ncbi.nlm.nih.gov/pubmed/28099151
http://dx.doi.org/10.18632/oncotarget.14636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355138/
https://www.ncbi.nlm.nih.gov/pubmed/28099151
http://dx.doi.org/10.18632/oncotarget.14636

Ejemplares similares